<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02978183</url>
  </required_header>
  <id_info>
    <org_study_id>ST266-AC-201</org_study_id>
    <nct_id>NCT02978183</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis</brief_title>
  <official_title>A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Noveome Biotherapeutics, formerly Stemnion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Noveome Biotherapeutics, formerly Stemnion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of ST266 ophthalmic drops compared to&#xD;
      placebo for the treatment of the signs and symptoms of allergic conjunctivitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multi-center, double-masked, randomized, placebo-controlled, modified&#xD;
      conjunctival allergen challenge (CAC) model. The primary endpoints of ocular itching and&#xD;
      conjunctival redness will be evaluated at the subject's final visit. Subjects who meet&#xD;
      inclusion criteria will be randomized to one of two treatment groups (1:1). Randomization&#xD;
      will be stratified by average post-CAC itching scores at baseline.&#xD;
&#xD;
      Subjects will be evaluated at baseline and on Days 6, 7 and 8.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Itching</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Ocular itching evaluated by the subject. Ocular itching was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less itching.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Redness</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Conjunctival redness evaluated by the investigator. Conjunctival redness was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less redness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ciliary Redness</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Ciliary redness evaluated by the investigator. Ciliary redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episcleral Redness</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Episcleral redness evaluated by the investigator. Episcleral redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chemosis</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Chemosis evaluated by the investigator. Chemosis was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less chemosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eyelid Swelling</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Eyelid swelling evaluated by the subject. Eyelid swelling was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less swelling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tearing/Watery Eyes</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Tearing evaluated by the subject. Tearing was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less tearing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinorrhea</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Rhinorrhea evaluated by the subject. Rhinorrhea was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Pruritus</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Nasal Pruritus evaluated by the subject. Nasal pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ear or Palate Pruritus</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Ear or palate pruritus evaluated by the subject. Ear or palate pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Congestion</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>Nasal congestion evaluated by the subject. Nasal congestion was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Composite Score</measure>
    <time_frame>Day 7 and 8</time_frame>
    <description>A composite score of presence or absence of at least one nasal symptom evaluated by the subject</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Allergic Conjunctivitis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1X ST266 dosed 4 times a day for 8 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo dosed 4 times a day for 8 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ST266</intervention_name>
    <description>One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline (0.9% NaCl)</intervention_name>
    <description>One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  be at least 18 years of age of either gender and any race;&#xD;
&#xD;
          -  provide written informed consent and sign the HIPAA form;&#xD;
&#xD;
          -  be willing and able to follow all instructions and attend all study visits; have a&#xD;
             positive history of ocular allergies and a positive skin test reaction to a seasonal&#xD;
             AND perennial allergen as confirmed by an allergic skin test;&#xD;
&#xD;
          -  be able and willing to avoid all disallowed medication for the appropriate washout&#xD;
             period and during the study;&#xD;
&#xD;
          -  be able and willing to discontinue wearing contact lenses for at least 72 hours prior&#xD;
             to and during the study trial period;&#xD;
&#xD;
          -  (for females capable of becoming pregnant) agree to have urine pregnancy testing&#xD;
             performed at screening (must be negative) and at the study exit; must not be&#xD;
             lactating; and must agree to use a medically acceptable form of birth control&#xD;
             throughout the study duration and for at least 14 days prior to instillation of&#xD;
             investigational product). Women considered capable of becoming pregnant include all&#xD;
             females who have experienced menarche and have not experienced menopause (as defined&#xD;
             by amenorrhea for greater than 12 consecutive months) or have not undergone successful&#xD;
             surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral&#xD;
             oophorectomy);&#xD;
&#xD;
          -  have a calculated visual acuity of 0.7 logMAR or better in each eye as measured using&#xD;
             an ETDRS chart;&#xD;
&#xD;
          -  have a positive post-CAC reaction;&#xD;
&#xD;
          -  have a positive post-CAC reaction in two out of the first three time points;&#xD;
&#xD;
          -  be able to self-administer eye drops satisfactorily or have a caregiver at home&#xD;
             routinely available for this purpose.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  have known contraindications or sensitivities to the use of the investigational&#xD;
             product or any of its components;&#xD;
&#xD;
          -  have any ocular condition that, in the opinion of the investigator, could affect the&#xD;
             subject's safety or trial parameters (including but not limited to narrow angle&#xD;
             glaucoma, clinically significant blepharitis, follicular conjunctivitis, iritis, or&#xD;
             pterygium);&#xD;
&#xD;
          -  have had ocular surgical intervention within 3 months prior to initiating the study or&#xD;
             during the study and/or a history of refractive surgery within the past 6 months;&#xD;
&#xD;
          -  have a known history of retinal detachment, diabetic retinopathy, or active retinal&#xD;
             disease;&#xD;
&#xD;
          -  have the presence of an active ocular infection (bacterial, viral or fungal) or&#xD;
             positive history of an ocular herpetic infection at any visit;&#xD;
&#xD;
          -  use any of the disallowed medications during the period indicated prior to and during&#xD;
             the study;&#xD;
&#xD;
          -  have any significant illness (e.g. any autoimmune disease requiring therapy, severe&#xD;
             cardiovascular disease [including arrhythmias]) the investigator feels could be&#xD;
             expected to interfere with the subject's health or with the study parameters and/or&#xD;
             put the subject at any unnecessary risk (includes but is not limited to: poorly&#xD;
             controlled hypertension or poorly controlled diabetes, a history of status&#xD;
             asthmaticus, organ transplants, a known history of persistent moderate or severe&#xD;
             asthma, or a known history of moderate to severe allergic asthmatic reactions to any&#xD;
             of the study allergens);&#xD;
&#xD;
          -  manifest signs or symptoms of clinically active allergic conjunctivitis in either eye&#xD;
             at the screening visit;&#xD;
&#xD;
          -  have planned surgery (ocular or systemic) during the trial period or within 30 days&#xD;
             after;&#xD;
&#xD;
          -  have used an investigational drug or medical device within 30 days of the study or be&#xD;
             concurrently enrolled in another investigational product trial;&#xD;
&#xD;
          -  be a female who is currently pregnant, planning a pregnancy, or lactating.&#xD;
&#xD;
          -  have cancer or have a history of cancer within the last 5 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 28, 2016</study_first_submitted>
  <study_first_submitted_qc>November 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2016</study_first_posted>
  <results_first_submitted>August 16, 2021</results_first_submitted>
  <results_first_submitted_qc>September 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 16, 2021</results_first_posted>
  <disposition_first_submitted>September 24, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>September 24, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">September 26, 2018</disposition_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 13, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT02978183/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT02978183/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1</title>
          <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
        <group group_id="P2">
          <title>Group 2</title>
          <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
        <group group_id="B2">
          <title>Group 2</title>
          <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.5" spread="13.44"/>
                    <measurement group_id="B2" value="47" spread="13.98"/>
                    <measurement group_id="B3" value="45.3" spread="13.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Iris Color</title>
          <units>eyes</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hazel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Green</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Allergen Disposition</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Dust Mite</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dog Dander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cockroach</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cat Dander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ocular Itching</title>
        <description>Ocular itching evaluated by the subject. Ocular itching was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less itching.</description>
        <time_frame>Day 7 and 8</time_frame>
        <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Ocular Itching</title>
          <description>Ocular itching evaluated by the subject. Ocular itching was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less itching.</description>
          <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.508" spread="0.8373"/>
                    <measurement group_id="O2" value="0.139" spread="0.3131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 5 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.485" spread="0.9533"/>
                    <measurement group_id="O2" value="2.535" spread="1.1070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 7 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.559" spread="0.9887"/>
                    <measurement group_id="O2" value="2.576" spread="1.1113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.434" spread="0.9320"/>
                    <measurement group_id="O2" value="2.458" spread="1.1124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.154" spread="0.9415"/>
                    <measurement group_id="O2" value="2.181" spread="1.1520"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.838" spread="0.9960"/>
                    <measurement group_id="O2" value="1.910" spread="1.1482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.529" spread="0.9103"/>
                    <measurement group_id="O2" value="1.722" spread="1.1707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.346" spread="0.9435"/>
                    <measurement group_id="O2" value="1.583" spread="1.1164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.449" spread="0.7405"/>
                    <measurement group_id="O2" value="0.167" spread="0.3827"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 5 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.816" spread="0.8968"/>
                    <measurement group_id="O2" value="2.618" spread="0.9847"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 7 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.787" spread="0.9316"/>
                    <measurement group_id="O2" value="2.625" spread="0.9865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.588" spread="0.9903"/>
                    <measurement group_id="O2" value="2.604" spread="1.0357"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.309" spread="0.9654"/>
                    <measurement group_id="O2" value="2.299" spread="1.0804"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.081" spread="0.9389"/>
                    <measurement group_id="O2" value="1.986" spread="1.1354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.765" spread="0.9573"/>
                    <measurement group_id="O2" value="1.819" spread="1.1158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.493" spread="0.9262"/>
                    <measurement group_id="O2" value="1.590" spread="1.1167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0882</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 5 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8032</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 7 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9003</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9523</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9071</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7509</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2824</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4017</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4497</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1650</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 5 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3494</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 7 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4781</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9847</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9731</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6984</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6265</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7848</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5789</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Redness</title>
        <description>Conjunctival redness evaluated by the investigator. Conjunctival redness was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less redness.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Conjunctival Redness</title>
          <description>Conjunctival redness evaluated by the investigator. Conjunctival redness was evaluated on a 0-4 scale (with half unit increments allowed). Lower scores indicated less redness.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.103" spread="0.7541"/>
                    <measurement group_id="O2" value="1.028" spread="0.5818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.125" spread="0.8817"/>
                    <measurement group_id="O2" value="1.958" spread="0.8814"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.897" spread="0.9714"/>
                    <measurement group_id="O2" value="1.882" spread="0.9073"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.926" spread="1.0308"/>
                    <measurement group_id="O2" value="1.771" spread="0.8481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.875" spread="1.0005"/>
                    <measurement group_id="O2" value="1.743" spread="0.8377"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.816" spread="1.0323"/>
                    <measurement group_id="O2" value="1.681" spread="0.8775"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.912" spread="0.6682"/>
                    <measurement group_id="O2" value="0.819" spread="0.4766"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.963" spread="0.7909"/>
                    <measurement group_id="O2" value="1.917" spread="0.7319"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.963" spread="0.8075"/>
                    <measurement group_id="O2" value="2.111" spread="0.7870"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.882" spread="0.8101"/>
                    <measurement group_id="O2" value="1.951" spread="0.8036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.735" spread="0.8549"/>
                    <measurement group_id="O2" value="1.785" spread="0.8241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.596" spread="0.8791"/>
                    <measurement group_id="O2" value="1.625" spread="0.7476"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8165</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6590</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7455</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9212</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9509</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7897</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3183</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7604</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7343</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1530</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3307</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3399</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5137</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9962</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ciliary Redness</title>
        <description>Ciliary redness evaluated by the investigator. Ciliary redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Ciliary Redness</title>
          <description>Ciliary redness evaluated by the investigator. Ciliary redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.912" spread="0.6243"/>
                    <measurement group_id="O2" value="0.750" spread="0.5445"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.838" spread="0.8368"/>
                    <measurement group_id="O2" value="1.799" spread="0.8341"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.691" spread="0.9925"/>
                    <measurement group_id="O2" value="1.729" spread="0.8353"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.713" spread="0.9417"/>
                    <measurement group_id="O2" value="1.625" spread="0.8420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.654" spread="0.9150"/>
                    <measurement group_id="O2" value="1.583" spread="0.7488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.603" spread="0.9869"/>
                    <measurement group_id="O2" value="1.493" spread="0.8608"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.581" spread="0.6053"/>
                    <measurement group_id="O2" value="0.521" spread="0.4487"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.691" spread="0.8189"/>
                    <measurement group_id="O2" value="1.743" spread="0.7058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.699" spread="0.7804"/>
                    <measurement group_id="O2" value="1.931" spread="0.7310"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.625" spread="0.8556"/>
                    <measurement group_id="O2" value="1.792" spread="0.7688"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.463" spread="0.9027"/>
                    <measurement group_id="O2" value="1.569" spread="0.7806"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.346" spread="0.8528"/>
                    <measurement group_id="O2" value="1.458" spread="0.8007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3259</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9785</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5112</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7771</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6232</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8895</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8974</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9604</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5301</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0386</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1034</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0985</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2342</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3016</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Episcleral Redness</title>
        <description>Episcleral redness evaluated by the investigator. Episcleral redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Episcleral Redness</title>
          <description>Episcleral redness evaluated by the investigator. Episcleral redness was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less redness.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.029" spread="0.6622"/>
                    <measurement group_id="O2" value="0.910" spread="0.5579"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.868" spread="0.8217"/>
                    <measurement group_id="O2" value="1.819" spread="0.8401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.757" spread="0.9283"/>
                    <measurement group_id="O2" value="1.778" spread="0.8468"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.787" spread="0.9656"/>
                    <measurement group_id="O2" value="1.701" spread="0.8036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.721" spread="0.9939"/>
                    <measurement group_id="O2" value="1.618" spread="0.7500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.669" spread="1.0275"/>
                    <measurement group_id="O2" value="1.583" spread="0.8345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.507" spread="0.5822"/>
                    <measurement group_id="O2" value="0.424" spread="0.4544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.735" spread="0.8210"/>
                    <measurement group_id="O2" value="1.708" spread="0.6827"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.706" spread="0.8404"/>
                    <measurement group_id="O2" value="1.896" spread="0.7055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.647" spread="0.8144"/>
                    <measurement group_id="O2" value="1.701" spread="0.7508"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.412" spread="0.8680"/>
                    <measurement group_id="O2" value="1.583" spread="0.7488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.353" spread="0.8575"/>
                    <measurement group_id="O2" value="1.347" spread="0.7495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4927</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8686</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5772</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9700</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7516</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9532</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7522</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6804</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6267</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0976</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4687</p_value>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0421</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6085</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9634</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chemosis</title>
        <description>Chemosis evaluated by the investigator. Chemosis was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less chemosis.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Chemosis</title>
          <description>Chemosis evaluated by the investigator. Chemosis was evaluated on a 0-4 scale (with half unit increments allowed). A lower score was indicative of less chemosis.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.390" spread="0.3703"/>
                    <measurement group_id="O2" value="0.465" spread="0.3787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.765" spread="0.4306"/>
                    <measurement group_id="O2" value="0.840" spread="0.4711"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.669" spread="0.5391"/>
                    <measurement group_id="O2" value="0.708" spread="0.4762"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.691" spread="0.5709"/>
                    <measurement group_id="O2" value="0.778" spread="0.4259"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.691" spread="0.6001"/>
                    <measurement group_id="O2" value="0.785" spread="0.5146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.676" spread="0.6047"/>
                    <measurement group_id="O2" value="0.757" spread="0.4075"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.081" spread="0.2280"/>
                    <measurement group_id="O2" value="0.104" spread="0.1925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.574" spread="0.6262"/>
                    <measurement group_id="O2" value="0.674" spread="0.4994"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.632" spread="0.7288"/>
                    <measurement group_id="O2" value="0.764" spread="0.4265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.684" spread="0.7792"/>
                    <measurement group_id="O2" value="0.708" spread="0.4571"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.566" spread="0.7444"/>
                    <measurement group_id="O2" value="0.590" spread="0.5674"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.551" spread="0.8137"/>
                    <measurement group_id="O2" value="0.493" spread="0.6196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3322</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8026</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9981</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5645</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5455</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6980</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6115</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4528</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7551</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5318</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9748</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7706</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3414</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4361</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Eyelid Swelling</title>
        <description>Eyelid swelling evaluated by the subject. Eyelid swelling was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less swelling.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Eyelid Swelling</title>
          <description>Eyelid swelling evaluated by the subject. Eyelid swelling was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less swelling.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" spread="0.711"/>
                    <measurement group_id="O2" value="0.22" spread="0.404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.889"/>
                    <measurement group_id="O2" value="1.39" spread="0.871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.25" spread="0.915"/>
                    <measurement group_id="O2" value="1.33" spread="0.837"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" spread="0.776"/>
                    <measurement group_id="O2" value="1.25" spread="0.841"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" spread="0.711"/>
                    <measurement group_id="O2" value="1.22" spread="0.857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="0.780"/>
                    <measurement group_id="O2" value="0.97" spread="0.836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="0.621"/>
                    <measurement group_id="O2" value="0.26" spread="0.500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="0.744"/>
                    <measurement group_id="O2" value="1.21" spread="0.873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" spread="0.740"/>
                    <measurement group_id="O2" value="1.19" spread="0.881"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" spread="0.817"/>
                    <measurement group_id="O2" value="1.11" spread="0.887"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.766"/>
                    <measurement group_id="O2" value="1.10" spread="0.893"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" spread="0.728"/>
                    <measurement group_id="O2" value="0.89" spread="0.887"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0603</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4857</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9815</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6213</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1831</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6489</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2622</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2397</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3202</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2663</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5672</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5055</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8143</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6901</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tearing/Watery Eyes</title>
        <description>Tearing evaluated by the subject. Tearing was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less tearing.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Tearing/Watery Eyes</title>
          <description>Tearing evaluated by the subject. Tearing was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less tearing.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" spread="0.707"/>
                    <measurement group_id="O2" value="0.21" spread="0.437"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.966"/>
                    <measurement group_id="O2" value="1.38" spread="1.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="1.038"/>
                    <measurement group_id="O2" value="1.22" spread="1.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="0.898"/>
                    <measurement group_id="O2" value="1.07" spread="0.965"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.930"/>
                    <measurement group_id="O2" value="0.94" spread="1.034"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.875"/>
                    <measurement group_id="O2" value="0.85" spread="0.909"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.810"/>
                    <measurement group_id="O2" value="0.28" spread="0.553"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="1.074"/>
                    <measurement group_id="O2" value="1.15" spread="0.970"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.04" spread="1.090"/>
                    <measurement group_id="O2" value="1.13" spread="0.929"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.87" spread="0.864"/>
                    <measurement group_id="O2" value="1.01" spread="0.906"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.809"/>
                    <measurement group_id="O2" value="1.00" spread="0.956"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.803"/>
                    <measurement group_id="O2" value="0.88" spread="0.952"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4032</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2946</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2863</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0891</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5347</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3733</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2506</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8667</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7640</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8008</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4729</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4742</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2922</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3657</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rhinorrhea</title>
        <description>Rhinorrhea evaluated by the subject. Rhinorrhea was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
        <time_frame>Day 7 and 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Rhinorrhea</title>
          <description>Rhinorrhea evaluated by the subject. Rhinorrhea was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.595"/>
                    <measurement group_id="O2" value="0.19" spread="0.525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="1.152"/>
                    <measurement group_id="O2" value="1.47" spread="1.134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="0.904"/>
                    <measurement group_id="O2" value="1.31" spread="1.142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" spread="0.870"/>
                    <measurement group_id="O2" value="0.97" spread="1.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.821"/>
                    <measurement group_id="O2" value="0.89" spread="1.090"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.784"/>
                    <measurement group_id="O2" value="0.94" spread="1.068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.579"/>
                    <measurement group_id="O2" value="0.22" spread="0.591"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" spread="0.938"/>
                    <measurement group_id="O2" value="1.39" spread="1.225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread="0.963"/>
                    <measurement group_id="O2" value="1.31" spread="1.283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="0.933"/>
                    <measurement group_id="O2" value="1.08" spread="1.156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="0.853"/>
                    <measurement group_id="O2" value="0.92" spread="1.180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.776"/>
                    <measurement group_id="O2" value="0.83" spread="1.108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6600</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6877</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3340</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7874</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3812</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6987</p_value>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6832</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8521</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7516</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6252</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8321</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8173</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5445</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6810</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasal Pruritus</title>
        <description>Nasal Pruritus evaluated by the subject. Nasal pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
        <time_frame>Day 7 and 8</time_frame>
        <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Nasal Pruritus</title>
          <description>Nasal Pruritus evaluated by the subject. Nasal pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
          <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" spread="0.467"/>
                    <measurement group_id="O2" value="0.06" spread="0.232"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.141"/>
                    <measurement group_id="O2" value="1.11" spread="1.116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" spread="0.965"/>
                    <measurement group_id="O2" value="1.03" spread="1.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.923"/>
                    <measurement group_id="O2" value="0.89" spread="0.950"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.890"/>
                    <measurement group_id="O2" value="0.83" spread="0.971"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.774"/>
                    <measurement group_id="O2" value="0.75" spread="0.967"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.554"/>
                    <measurement group_id="O2" value="0.14" spread="0.487"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.167"/>
                    <measurement group_id="O2" value="0.94" spread="1.145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.087"/>
                    <measurement group_id="O2" value="0.83" spread="1.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" spread="1.111"/>
                    <measurement group_id="O2" value="0.69" spread="1.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.912"/>
                    <measurement group_id="O2" value="0.69" spread="1.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="0.821"/>
                    <measurement group_id="O2" value="0.64" spread="1.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0111</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3391</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2390</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3068</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4914</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5185</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5262</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6098</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8849</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6941</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5728</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5931</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7513</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7297</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ear or Palate Pruritus</title>
        <description>Ear or palate pruritus evaluated by the subject. Ear or palate pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
        <time_frame>Day 7 and 8</time_frame>
        <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Ear or Palate Pruritus</title>
          <description>Ear or palate pruritus evaluated by the subject. Ear or palate pruritus was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
          <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.595"/>
                    <measurement group_id="O2" value="0.19" spread="0.401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread="1.355"/>
                    <measurement group_id="O2" value="1.22" spread="1.245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="1.193"/>
                    <measurement group_id="O2" value="1.11" spread="1.214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="1.073"/>
                    <measurement group_id="O2" value="1.08" spread="1.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" spread="0.965"/>
                    <measurement group_id="O2" value="0.94" spread="1.094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.808"/>
                    <measurement group_id="O2" value="0.83" spread="0.971"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.239"/>
                    <measurement group_id="O2" value="0.19" spread="0.401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="1.336"/>
                    <measurement group_id="O2" value="1.33" spread="1.352"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="1.282"/>
                    <measurement group_id="O2" value="1.28" spread="1.344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" spread="1.274"/>
                    <measurement group_id="O2" value="1.19" spread="1.283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="1.181"/>
                    <measurement group_id="O2" value="1.08" spread="1.204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="1.128"/>
                    <measurement group_id="O2" value="0.97" spread="1.253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1259</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9234</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8816</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5703</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5428</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7454</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8195</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0909</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4881</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3391</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6065</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3393</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8364</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8858</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasal Congestion</title>
        <description>Nasal congestion evaluated by the subject. Nasal congestion was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
        <time_frame>Day 7 and 8</time_frame>
        <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Nasal Congestion</title>
          <description>Nasal congestion evaluated by the subject. Nasal congestion was evaluated on a 0-4 scale in which 0.5 unit increments were not allowed. A lower score was indicative of less severity.</description>
          <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="0.816"/>
                    <measurement group_id="O2" value="0.42" spread="0.906"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.44" spread="1.160"/>
                    <measurement group_id="O2" value="1.47" spread="1.230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.41" spread="1.048"/>
                    <measurement group_id="O2" value="1.36" spread="1.099"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" spread="0.987"/>
                    <measurement group_id="O2" value="1.22" spread="1.072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.989"/>
                    <measurement group_id="O2" value="1.22" spread="1.174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" spread="1.008"/>
                    <measurement group_id="O2" value="1.17" spread="1.159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="0.662"/>
                    <measurement group_id="O2" value="0.33" spread="0.717"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" spread="1.060"/>
                    <measurement group_id="O2" value="1.36" spread="1.199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="1.070"/>
                    <measurement group_id="O2" value="1.39" spread="1.293"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread="1.024"/>
                    <measurement group_id="O2" value="1.28" spread="1.279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="0.968"/>
                    <measurement group_id="O2" value="1.28" spread="1.210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="1.048"/>
                    <measurement group_id="O2" value="1.22" spread="1.222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8818</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8679</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7856</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7507</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8189</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9206</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9591</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: Pre-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5302</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7591</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8978</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7179</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7262</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 Minutes Post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8275</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: All Post-CAC Time Points</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6180</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasal Composite Score</title>
        <description>A composite score of presence or absence of at least one nasal symptom evaluated by the subject</description>
        <time_frame>Day 7 and 8</time_frame>
        <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Nasal Composite Score</title>
          <description>A composite score of presence or absence of at least one nasal symptom evaluated by the subject</description>
          <population>Pre-Conjunctival Allergen Challenge not evaluated in subject 1-011 on visit 5B</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7, Pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, pre-Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 10 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 15 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 20 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 25 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8, 30 Minutes Post Conjunctival Allergen Challenge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Absent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PResent</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 10 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity were not employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 15 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 20 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 25 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7312</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 7: 30 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 10 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 15 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 20 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 25 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4297</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Day 8: 30 minutes post-CAC</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4791</p_value>
            <p_value_desc>Adjustments for multiplicity will not be employed</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were assessed for subjects over a period of 8 days during active treatment. If an AE was unresolved at the final study visit Investigators were instructed to follow-up with subjects until the AE resolved or they were lost to follow-up. If the patient is lost to follow-up, the Investigator should make 3 reasonable attempts to contact the patient via telephone, post, or certified mail.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>1X ST266 dosed 4 times a day for 8 days&#xD;
ST266: One (1) drop of 1X ST266 ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
        <group group_id="E2">
          <title>Group 2</title>
          <description>Placebo dosed 4 times a day for 8 days&#xD;
Saline (0.9% NaCl): One (1) drop of saline ophthalmic eye drops will be administered to each eye 4 times a day for 8 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Visual Acuity Reduced</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infected Bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Steed, MD</name_or_title>
      <organization>Noveome Biotherapeutics, Inc</organization>
      <phone>4124029913</phone>
      <email>dsteed@noveome.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

